HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Targeted delivery of small interfering RNA to angiogenic endothelial cells with liposome-polycation-DNA particles.

Abstract
Angiogenesis is an attractive target for cancer therapy, due to its central position in tumor growth and development. Vascular Endothelial Growth Factor (VEGF) and its receptors (VEGFRs) play a key role in the angiogenic process. A promising strategy for targeting VEGF-mediated angiogenesis is RNA interference (RNAi) using short interfering RNA (siRNA). However, for efficacious RNAi a well-designed siRNA delivery system is crucial. Liposome-Polycation-DNA (LPD) particles form a promising system for siRNA delivery to tumors. In order to target angiogenic endothelial cells, LPD particles may be modified with a targeting ligand, such as a cyclic Arg-Gly-Asp (RGD) peptide that specifically binds to integrins expressed on tumor-associated endothelial cells. In the current study, RGD-targeted PEGylated LPD particles containing VEGFR-2 siRNA were prepared and optimized with respect to their size and charge by varying protamine content, carrier DNA content for stronger complexation, and PEGylation density. The size of the optimized particles was around 200 nm and the ΞΆ-potential was approximately +20 mV. The uptake and silencing efficacy of the RGD-targeted PEGylated LPD particles were evaluated in H5V cells (murine endothelial cells) and Human Umbilical Vein Endothelial cells (HUVECs). When compared to non-targeted LPD particles, enhanced uptake and silencing of VEGFR-2 expression was observed for RGD-targeted PEGylated LPD particles. In conclusion, the RGD-targeted PEGylated LPD particles containing VEGFR-2 siRNA presented here may be a promising approach for targeting VEGF-mediated angiogenesis in cancer therapy.
AuthorsP Vader, B J Crielaard, S M van Dommelen, R van der Meel, G Storm, R M Schiffelers
JournalJournal of controlled release : official journal of the Controlled Release Society (J Control Release) Vol. 160 Issue 2 Pg. 211-6 (Jun 10 2012) ISSN: 1873-4995 [Electronic] Netherlands
PMID21983283 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011 Elsevier B.V. All rights reserved.
Chemical References
  • Drug Carriers
  • Liposomes
  • Polyamines
  • Polyelectrolytes
  • RNA, Small Interfering
  • polycations
  • DNA
  • calf thymus DNA
  • Vascular Endothelial Growth Factor Receptor-2
Topics
  • Animals
  • Blotting, Western
  • Cell Culture Techniques
  • DNA (chemistry)
  • Drug Carriers (chemistry)
  • Endothelial Cells (metabolism, pathology)
  • Gene Silencing
  • Human Umbilical Vein Endothelial Cells
  • Humans
  • Liposomes
  • Mice
  • Neovascularization, Pathologic (metabolism, pathology)
  • Particle Size
  • Polyamines (chemistry)
  • Polyelectrolytes
  • RNA, Small Interfering (administration & dosage, genetics)
  • Vascular Endothelial Growth Factor Receptor-2 (antagonists & inhibitors, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: